Search the Newsreel

Aspen Aerogels Inc (ASPN) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Aspen Aerogels Inc (ASPN), noting its robust financial status and high operating efficiency with a current financial score of 7.46, ranking 27 out of 65 in the Chemicals industry. Despite these strengths, the company experienced a significant …

Ocado backs down from £190m fight with M&S

Ocado had threatened legal action against M&S - Hollie Adams/Bloomberg Finance LP Ocado has abandoned an attempt to force Marks & Spencer to hand over a £190m payment tied to the companies' online grocery joint venture. M&S is not expected to make a payment …

Aspen Group Limited Revenue Breakdown – ASX:APZ

Aspen Aerogels Inc (ASPN) Cash Flow

This article provides a detailed historical overview of Aspen Aerogels Inc.'s (ASPN) cash flow statements, including operating, investing, and financing activities, presented quarterly and annually. It includes specific financial figures for various cash flow components spanning several years. The page also features an FAQ …

Aspen Aerogels Inc (ASPN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Aspen Aerogels Inc (ASPN), categorized by business segments and geographical regions. It shows that the "Thermal barrier" segment accounts for 62.30% of revenue and "Energy industrial" for 37.70%. Geographically, the United States is the largest contributor, …

ASPN,DMRC Volatility & Greeks

This article provides a detailed financial overview of Aspen Aerogels Inc (ASPN) and Digimarc Corp (DMRC), including their stock performance, key financial metrics, and market data as of July 27. It lists various ratios, growth rates, insider and institutional ownership, and analyst recommendations for …

ASPN|Aspen Aerogels Inc|Price:4.670|Chg%:-0.495

This article provides a detailed financial overview of Aspen Aerogels Inc (ASPN), offering insights into its income statement, balance sheet, and cash flow statement. It highlights the company's latest earnings reports, including revenue, EPS, net profit, and various financial ratios like net margin, gross …

Aspen Aerogels, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call

Aspen Aerogels, Inc. (NYSE: ASPN) has announced that it will release its second quarter financial results for the period ending June 30, 2026, on Thursday, August 6, 2026, before the market opens. Following the release, President & CEO Don Young and CFO & Treasurer …

Aspen Aerogels Expects Q2 Results Before Aug. 6 Open

Aspen Aerogels (NYSE: ASPN) announced it will release its second-quarter 2026 financial results before the market opens on Thursday, August 6, 2026. Management will then host a conference call at 8:30 a.m. ET to discuss the results, with access available via dial-in numbers and …

ASPN stock holds support after recent Aerogel update

This article states that Aspen Aerogels (ASPN) stock is holding support following an update related to its Aerogel context. The piece emphasizes that with no current verifiable quote or fresh company release, investors should monitor official investor relations communications for updates on revenue conversion, …

Aspen Pharmacare Canada receives Health Canada approval for a generic equivalent of Ozempic®

New generic equivalent of Ozempic® expected to help expand access to semaglutide treatment options for adults with type 2 diabetes in Canada OAKVILLE, ON, July 21, 2026 /CNW/ -- Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited ("Aspen"), today announced that …

Aspen Aerogels stock trades around recent lows as margin pressure offsets revenue growth

Aspen Aerogels Inc. (ASPN) shows a mixed financial picture with strong revenue growth in 2023 and early 2024, driven by demand for its aerogel products in battery and industrial markets. However, the company continues to report net losses and suffers from margin pressure due …

Enterprise value to EBIT forward of Aspen Aerogels, Inc. – NYSE:ASPN

This article displays the "Enterprise value to EBIT forward" metric for Aspen Aerogels, Inc. (NYSE: ASPN) on the TradingView platform. It presents the value and change over a period, indicating it's a financial data point for the company. The content primarily focuses on presenting …

ASPN stock rises on fresh 2026 report context

ASPN stock is seeing an uptick due to the context of its 2026 report, which relies on Aspen Aerogels' latest financial filings. The company reported a 23% revenue increase to $441.0 million in fiscal 2025, alongside a narrowed net loss of $107.7 million, showing …

Spenda Limited (ASX:SPX) Security Suspension Leaves Ordinary Shares Unaffected

Why Marks and Spencer Group's (LON:MKS) Shaky Earnings Are Just The Beginning Of Its Problems

Aspen Group (ASX:APZ) Shares Decline Amid Light Trading Activity

Aspen Pharmacare's $1.6 billion APAC sale adds $33 million to Stephen Saad's net worth

Marks and Spencer Group's (LON:MKS) Soft Earnings Are Actually Better Than They Appear

Spencer's Retail FY26 net loss at ₹249.33 crore

Earnings Miss: Marks and Spencer Group plc Missed EPS By 33% And Analysts Are Revising Their Forecasts

Marks & Spencer Earnings: Decent End to a Challenging Year

Is Spenda (ASX:SPX) Next Undervalued Fintech Growth Stock?

Marks & Spencer Share Price in Focus – Shore Capital Says Retailer ‘Back in Control’

Marks & Spencer exits its worst year in a decade with momentum intact

Stephen Saad's Aspen Pharmacare predicts double-digit growth despite tough first half

South Africa’s Aspen Pharmacare Reports Earnings Drop as Restructuring Costs Bite

Aspen Group (ASX:APZ) Is Up 8.1% After Lifting Revenue And Clarifying 2026 Dividend Guidance – Has The Bull Case Changed?

Don't Ignore The Insider Selling In Marks and Spencer Group

Investors in Aspen Pharmacare Holdings (JSE:APN) from a year ago are still down 25%, even after 13% gain this past week

Is Marks & Spencer the FTSE 100’s most overvalued stock?

Spencer's Retail Q3 loss widens to Rs 58.4 cr, revenue slips marginally

The 5.8% return this week takes Marks and Spencer Group's (LON:MKS) shareholders five-year gains to 205%

Marks and Spencer Group (LON:MKS) Has A Somewhat Strained Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) 29% Share Price Surge Not Quite Adding Up

Marks & Spencer: Strong Food Performance Offsets Fashion Decline